BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33706324)

  • 1. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
    Guo H; Chen H; Wang W; Chen L
    Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
    Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
    Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
    Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and clinic-pathologic characteristics of ovarian tumor with different histologic subtypes-a SEER database population study of 41,376 cases.
    Shao C; Guo H; Chen L; Chen J; Wang L; Wang H
    Transl Cancer Res; 2023 Aug; 12(8):1937-1950. PubMed ID: 37701106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
    Wang J; Chen R; Li J; Lu X
    Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zhang C; Xi X
    Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
    Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
    Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
    Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS
    Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features and Survival Outcomes in Children and Adolescents With Malignant Mediastinal Germ Cell Tumors Based on Surveillance, Epidemiology, and End Results Database Analysis.
    Wu P; Yang Y; Yu Z; Zhao L; Feng S
    J Surg Res; 2023 Aug; 288():362-371. PubMed ID: 37062232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
    Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
    Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
    Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
    Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.
    Karalok A; Comert GK; Kilic C; Turkmen O; Kilic F; Basaran D; Boyraz G; Tekin ÖM; Turan T
    J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):461-466. PubMed ID: 31228608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.